Online ISSN: 1947-6027
About Genes & Cancer
Our mission is to combine research from the fields of genomics, bioinformatics, and modem genetics to determine how cancer cells overcome growth regulatory pathways. We aim to cover all aspects of oncogenes, growth suppressor and apoptotic genes, and their roles in tumor development.

Genes & Cancer | Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations

Genes & Cancer

September 30, 2022
PRESS RELEASE: A new editorial paper was published in Genes & Cancer on August 29, 2022, entitled, “Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.” continue reading »

Cell Cycle Mechanism as Potential Target to Treat Array of Cancers

Genes & Cancer

September 12, 2022
In a recently published Genes & Cancer review paper, researchers discuss the role of CDK4 in cell cycle control, normal development, tumorigenesis, and cancer therapeutics. continue reading »

Genes & Cancer | Using Quantitative Immunohistochemistry in Patients at High Risk for Hepatocellular Cancer

Genes & Cancer

August 22, 2022
PRESS RELEASE: A new research paper was published in Genes & Cancer on June 6, 2022, entitled, “Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer.” continue reading »

Common Bacteria Associated With Gastric Cancer and New Biomarkers

Genes & Cancer

August 19, 2022
Researchers investigated the expression of two lncRNAs in gastric cancer tissues and evaluated their association with a common strain of bacteria. continue reading »

Biomarker Detects Hepatocellular Carcinoma in Liver Cirrhosis

Genes & Cancer

July 30, 2022
Researchers developed an artificial intelligence-based process to differentiate hepatocellular carcinoma (HCC) from cirrhotic tissues and investigated potential biomarkers that may predict the risk of HCC in patients with cirrhosis. continue reading »